✦ LIBER ✦

PCV51 Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Adult Patients With Non-Valvular Atrial Fibrillation with One or More Risk Factors – A UK Perspective

✍ Scribed by Y. Asukai; A. Duran; A. Lloyd; E.J. McLeod; T. Evers; J. Broughton

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factors associated with increased mortal

✍ A. Vilches-Moraga; A. Alvarez-Pérez; E. Paredes-Galán; C. Rodriguez-Pascual; J.C 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 77 KB

Safety profile and efficacy of dabigatra

✍ A. Vilches-Moraga; J.C. Taboada-Rodriguez; C. Rodriguez-Pascual; E. Paredes-Galá 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 87 KB

PCV56 Cost-Effectiveness of Dabigatran E

✍ V. Nasciben; M.J.D.O. Figueiredo; F.C.D.C. Darrieux; L.S.P. Piegas; S.C.O. Marti 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV48 Cost-Effectiveness of Dabigatran E

✍ V. Nasciben; M.J.D.O. Figueiredo; S.C.O. Martins; L.S.P. Piegas 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCV7 A Mixed Treatment Comparison (MTC)

✍ S.J. Edwards; V. Hamilton; L. Nherera; N. Trevor; S. Barton 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Oral direct thrombin inhibitor AZD0837 f

✍ Gregory Y.H. Lip; Lars H. Rasmussen; S. Bertil Olsson; Sofia Zetterstrand; Chris 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 659 KB